Skip to main content

Table 1 Trial measures and timing.

From: Protocol for the MoleMate™ UK Trial: a randomised controlled trial of the MoleMate system in the management of pigmented skin lesions in primary care [ISRCTN 79932379]

 

Time after 1st Lead Clinician (LC) consultation

 

All participants

Non-referred participants

Referred participants

 

1st LC

consultation

up to 1

week

3 months

6 months

within 2

weeks

Clinical assessment of lesion(s)

  

Psychological measures (questionnaire)

     

Anxiety: short form STAI

 

  

Cancer worry: modified cancer worry scale

 

  

Satisfaction with LC consultation¥

 

   
  1. Spielberger State-Trait Anxiety Inventory
  2. ¥ Items from Europep instrument relating to the dimensions of care